Page 30 - 20. COMPILER QB - INDAS 102

For the year ended 31st March 2019
Ind AS 102 requires the entity to recognise the effects of repricing that increase the total fair value
of the share-based payment arrangement or are otherwise beneficial to the employee.
If the repricing increases the fair value of the equity instruments granted standard requires the
entity to include the incremental fair value granted (ie the difference between the fair value of the
repriced equity instrument and that of the original equity instrument, both estimated as at the date
of the modification) in the measurement of the amount recognised for services received as
consideration for the equity instruments granted.
If the repricing occurs during the vesting period, the incremental fair value granted is included in the
measurement of the amount recognised for services received over the period from the repricing date
until the date when the repriced equity instruments vest, in addition to the amount based on the
grant date fair value of the original equity instruments, which is recognised over the remainder of
the original vesting period. Accordingly, the amounts recognised are as follows:
Year Calculation Compensation expense Cumulative
ended for period compensation
expense
Rs. Rs.
31 March, [Rs.129 x 150 awards x 900 employees x 58,05,500 58,05,000
2018 (1 year /3 years of service)]
31 March, [Rs.129 x 150 awards x 950 employees x 85,87,500 1,43,92,500
2019 (2 year /3 years of service)] + (80-
50) x 150 awards x 950 employees x (1
year / 2 years of service) - 58,05,000
31 March, [(Rs.129 + 30) x 150 awards x 930 77,88,000 2,21,80,500
2020 employees] - 1,43,92,500

Journal Entry
31st March, 2018

Employee benefits expenses Dr. 58,05,000
To Outstanding Share based payment option 58,05,000
(Fair value of the liability recognized)
31st March, 2019
Employee benefits expenses Dr. 85,87,500
To Outstanding Share based payment option 85,87,500
(Fair value of the liability re-measured)
31st March, 2020
Employee benefits expenses Dr. 77,88,000
To Outstanding Share based payment option 77,88,000
(Fair value of the liability recognized)
Outstanding Share based payment option Dr. 2,21,80,500
To Equity share capital 2,21,80,500
(Being award settled)

20. 29